DIANA HAUSMAN
CIK 1563992 · Chief Medical Officer · last filed 2026-06-11
DIANA HAUSMAN is a Chief Medical Officer who has filed 25 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for IMRX, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.59M
4
25
-$3.21M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMRX | Director | 5,500 | $4.19 | $23.0K | $19.9K | 7 | 2026-06-11 |
| ZNTL | Chief Medical Officer | 373,876 | $3.75 | $1.40M | -$42.4K | 3 | 2024-05-09 |
| ZYME | Chief Medical Officer | 7,377 | $22.88 | $168.8K | -$3.22M | 10 | 2021-03-12 |
| Cascadian Therapeutics, Inc. (ONTY) Delisted | Chief Medical Officer | 5,747 | — | — | $26.7K | 5 | 2015-09-28 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | IMRX | Grant (A) | — | $0 | EDGAR |
| 2025-07-07 | IMRX | Buy (P) | +5,500 | $19.9K | EDGAR |
| 2025-06-16 | IMRX | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | IMRX | Grant (A) | — | $0 | EDGAR |
| 2024-05-09 | ZNTL | Sell (S) | −3,356 | -$42.4K | EDGAR |
| 2024-02-05 | ZNTL | Grant (A) | +337,500 | $0 | EDGAR |
| 2023-06-15 | IMRX | Grant (A) | — | $0 | EDGAR |
| 2023-05-10 | ZNTL | Grant (A) | +39,732 | $0 | EDGAR |
| 2022-06-23 | IMRX | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | IMRX | Grant (A) | — | $0 | EDGAR |